Global Spasticity Treatment Market – Industry Trends and Forecast to 2029

Market Analysis and Insights Global Spasticity Treatment Market

Spasticity treatment market size is projected to grow at a compound annual growth rate of 10.1% over the forecast period of 2022 to 2029. Data Bridge Market Research report on spasticity treatment market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecasted period while providing their impacts on the market’s growth.

Spasticity is basically a disorder of muscles that is generally characterized by continuous contraction of muscles causing tight or stiff muscles and results in inability to control those muscles. The sysmptoms of this disorder incudes overactive reflexes, increased muscle tone, spasm, abnormal posture and clonus. It causes injuries to brain or spinal cord tissues, which controls the voluntary movement, which results in the imbalance of signals between the nervous system and the voluntary muscles. It negatively affects muscles and joints of the limbs and is very harmful for the growing children.

The increasing popularity of physical therapy in the general public and across the globe is expected to accelerate the market growth in the forecast period of 2022 to 2029. Furthermore, the several advantages associated with physiotherapy are encouraging various hospitals to invest in a physiotherapy centers will further carve the way for the growth of the market. The development of stimulatory devices built in with advanced technologies and rising spending on public health programs are expected to boost the overall growth of the market. However, the lack of awareness amongst people about spasticity in developing nations and also hampers the overall growth of the market. Moreover, the adverse effects associated with drugs administered are also expected to restrict the overall growth of the market.

In addition, increasing global healthcare expenditure, launch of novel therapeutics, rising per capita income in emerging markets and the time required to gain results of physical therapy are likely to create various new opportunities that will impact this spasticity treatment market growth in the forecast period of 2022 to 2029. On the flip side, the inadequate reimbursement and lack of availability of skilled professionals is estimated to challenge the market’s growth.

This spasticity treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the spasticity treatment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Spasticity Treatment Market Scope and Market Size

Spasticity treatment market is segmented on the basis of therapy, treatment, drugs, route of administration, indication, distribution channel and end-users. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of therapy, the spasticity treatment market is segmented as physical therapy and occupational therapy.
• On the basis of treatment, the spasticity treatment market is segmented as medication and surgery.
• On the basis of drugs, the spasticity treatment market is segmented as baclofen, dantrolene sodium, gabapentin and others.
• On the basis of route of administration, the spasticity treatment market is segmented into oral, intramuscular and others.
• On the basis of indication, the spasticity treatment market is segmented as multiple sclerosis (MS), cerebral palsy (CP), traumatic brain injury (TBI) and others.
• On the basis of distribution channel, the spasticity treatment market is segmented as hospital pharmacy, online pharmacy and retail pharmacy.
• Based on end-users, the spasticity treatment market is segmented into hospitals, homecare, specialty clinics and others.

Spasticity Treatment Market Country Level Analysis

Spasticity treatment market is segmented on the basis of therapy, treatment, drugs, route of administration, indication, distribution channel and end-users.

The countries covered in the spasticity treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America leads the spasticity treatment market due to the increasing levels of investment for the development of advanced technologies such as cryotherapy, revascularization, cardiogenic shock and others in this region. Asia-Pacific region, on the other hand is expected to expand at a significant growth rate because of the increasing population along with advancement of healthcare infrastructure.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Spasticity treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Spasticity Treatment Market Share Analysis

Spasticity treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to spasticity treatment market.

Some of the major players operating in the spasticity treatment market report are F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Medtronic, ALLERGAN, Pfizer Inc, Ipsen Pharma, UCB Pharma Ltd, Sanofi, INMED PHARMACEUTICALS INC, Orient Pharma, Taj Pharmaceuticals Limited, Johnson & Johnson Services, Inc., MediciNova, Inc., Sun Pharmaceutical Industries Ltd, Novartis AG, Teva Pharmaceutical Industries Ltd, Merz Pharma, GW Pharmaceuticals plc, Revance Therapeutics, Inc, and Acorda Therapeutics, Inc., among others.

SKU-50493